JAGX — Jaguar Animal Health Inc · rev $1.2M

Jaguar Animal Health Inc (JAGX) is a biotechnology company listed on NASDAQ.

Latest reported JAGX revenue for 2026-06-30 was $1.2M. Net income was -$12.8M. Revenue was down 94.0% from 2026-03-31 to 2026-06-30. JAGX currently screens at market cap $1.7M.

Use this JAGX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the JAGX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the JAGX SEC filings page. Lician reads the product cache first so this HTML stays unique to Jaguar Animal Health Inc even when a live quote feed is slow.

Jaguar Animal Health Inc latest statements (FY2025)

Latest cached year on this hub. Full JAGX income, balance, and cash tables.

  • Revenue$11.5M
  • Net Income-$53.6M
  • Total Assets$38.3M
  • Total Debt$0
  • Free Cash Flow$0

JAGX recent filings